George Clinical: BioKorea 2016

George Clinical: BioKorea 2016

From the 30th March – 1 April 2016, George Clinical will be exhibiting at the largest Bio exhibition in Asia – Bio Korea 2016, held in Seoul. BioKorea, established in 2006, has grown to be one of Asia’s premier events for global biotech industry. This year marks the 11th anniversary for this conference. BioKorea consists […]

Read More

March 11th, 2016

Working With CRM to Move Malaysia Forward

The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-pro t organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research […]

Read More

February 22nd, 2016

Insights on the Clinical Trial Landscape of South Korea

Philip Gregory of George Clinical – China, highlight South Korea’s capabilities in a three part series originally published on http://innovations.bbkworldwide.com/part-ii-insights-on-the-clinical-trial-landscape-of-south-korea. He provides insight on its recent clinical research developments that are driving innovation across the Asia-Pacific region. South Korea In comparison to Japan, South Korea has had a longer history of conducting global clinical trials. In fact, more than […]

Read More

January 19th, 2016

China’s Future in Global Clinical Research

Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that discusses developments in the clinical trial landscape of East Asia and Japan. Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. With the world’s largest population, China’s recent changes to their clinical trial processes and […]

Read More

January 19th, 2016

Lowering blood pressure to decrease risk of cardiovascular events

Globally, there are millions of people that could benefit from an intensive lowering of blood pressure (BP). An individual with lower BP decreases their chances of suffering from any cardiovascular events such as: stroke, heart disease or heart attacks. A new study shows that lowering blood pressure to less than 140 mm Hg, the current […]

Read More

January 19th, 2016

Overcoming the Diversity in the South East Asian Region for a Global Clinical Trial

Sponsors are increasingly seeking emerging areas to conduct clinical trials for new patient pools and better recruitment. However, successful implementation of a global clinical trial in areas such as South East Asia requires operational strategies that circumvents the inherent diversity of these regions. In these regions, language, culture, infrastructure and resources are very different from […]

Read More

January 5th, 2016

A promising drug shows results in reducing the effects of Alzheimer’s disease

Alzheimer’s disease is currently the largest unmet medical need in neurology. More than 44 million people live with dementia worldwide, with Alzheimer’s being the most common form. As aging populations expand, it is critical that better treatments become available. George Clinical is currently managing a clinical trial in Australia of a new drug whose preliminary […]

Read More

November 17th, 2015

The Changing Role of the Data Manager

Throughout clinical trials, the data manager (DM) is heavily involved in constructing databases, managing reports, programming quality checks and managing the collection of data in the clinical trial. The DM is responsible for managing and training users the concepts of computerised clinical data base systems as well as fulfilling other duties such as design basic […]

Read More

November 11th, 2015

Link between birthweight and cancer confirmed by new research

New research from the International Childhood Cancer Cohort Consortium (I4C) confirms that childhood cancer is linked to birthweight. Childhood cancer appears to be slowly rising, at a rate of approximately 1% per year in developed countries. The I4C is an alliance of several large-scale studies of children that pools data on factors in relation to […]

Read More

November 11th, 2015

Working with CRM to move Malaysia forward

The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) […]

Read More

October 21st, 2015

Add George Clinical to your network